RUNX2 and Hyperglycemia: Hyperglycemia may inhibit genes related to osteogenic transdifferentiation and bone resorption, including metalloproteinase (MMP) 9 and carbonic anhydrase II (CAII), and also decrease the expressions of osteogenesis-related genes such as Runx2 and alkaline phosphatase (ALP) [18].